XNAS
ACTG
Market cap450mUSD
Jul 24, Last price
4.66USD
1D
0.87%
1Q
-4.12%
Jan 2017
-28.31%
Name
Acacia Research Corp
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Acacia Research Corporation, together with its associated entities, primarily concentrates on acquiring intellectual property and related high-yield assets. A core aspect of its business strategy involves the commercialization and defense of patented technologies through licensing. The enterprise operates through a dual-segment structure: Intellectual Property Operations and Industrial Operations. Through its Intellectual Property arm, Acacia manages extensive patent portfolios. These encompass both U.S. and international patents, protecting innovations applied across a broad spectrum of industries. Demonstrating substantial experience, it has successfully executed approximately 1,600 licensing agreements and overseen around 200 patent portfolio licensing and enforcement programs. The Industrial Operations segment is dedicated to the design, manufacture, and distribution of printers, parts, and consumable products. These offerings reach various industrial printing markets through a network of dealers and distributors. Additionally, it delivers specialized supply-chain printing solutions catering to sectors such as manufacturing, transportation and logistics, retail, food and beverage, and pharmaceuticals. The company also provides robust line matrix printers, vital for mission-critical applications including labeling, inventory management, build sheets, invoicing, and bills of lading. Founded in 1993, Acacia Research Corporation maintains its corporate headquarters in New York, New York.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||